Radhika Tripuraneni

Insider Reports History

Location
South San Francisco, CA
Signature
Jennifer Tousignant, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Radhika Tripuraneni:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Medical Officer Stock Option (Right to Buy) 95,800 02 Mar 2026 Direct
PROTHENA CORP PUBLIC LTD CO Chief Development Officer Stock Option (Right to Buy) 50,000 23 Feb 2022 Direct
Viridian Therapeutics, Inc.\DE Chief Medical Officer Restricted Stock Units 19,150 02 Mar 2026 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 1,697 01 Feb 2026 Direct

Insider Reports Filed by Radhika Tripuraneni

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRDN Viridian Therapeutics, Inc.\DE 02 Mar 2026 2 $0 4 Chief Medical Officer 04 Mar 2026, 18:51
TERN Terns Pharmaceuticals, Inc. 01 Feb 2026 1 $0 4 Director 02 Feb 2026, 18:07
TERN Terns Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 17:44
VRDN Viridian Therapeutics, Inc.\DE 10 Mar 2025 1 $0 4 Chief Medical Officer 12 Mar 2025, 16:36
VRDN Viridian Therapeutics, Inc.\DE 10 Mar 2025 0 $0 3 Chief Medical Officer 12 Mar 2025, 16:27
TERN Terns Pharmaceuticals, Inc. 01 Feb 2025 1 $0 4 Director 03 Feb 2025, 19:36
TERN Terns Pharmaceuticals, Inc. 01 Jul 2024 1 $0 4 Director 02 Jul 2024, 18:38
TERN Terns Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director 14 Jun 2024, 18:05
TERN Terns Pharmaceuticals, Inc. 12 Jun 2023 1 $0 4 Director 14 Jun 2023, 19:02
TERN Terns Pharmaceuticals, Inc. 26 Jul 2022 1 $0 4 Director 28 Jul 2022, 20:08
TERN Terns Pharmaceuticals, Inc. 26 Jul 2022 0 $0 3 Director 28 Jul 2022, 20:04
PRTA PROTHENA CORP PUBLIC LTD CO 23 Feb 2022 1 $0 4 Chief Development Officer 25 Feb 2022, 20:31